AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2012
Jun 4, 2012
34975_dirs_2012-06-04_bcada7e4-8085-4cee-99b6-45f5026273e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2012-06-04
Reporting Person: GREEN DAVID (Director, President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-01 | Common Stock | A | 88737 | — | Acquired | 1585287 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-01 | Stock option (right to buy) | $3.57 | A | 169929 | Disposed | 2022-06-01 | Common Stock, par value $0.01 per share (169929) | Direct |
Footnotes
F1: Includes (a) a deferred stock award of 66,800 restricted stock units which vest in equal installments on Jan 1, 2013 and Jan 1, 2014; (b) a deferred stock award of 40,312 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 88,737 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014, Jan 1, 2015 and Jan 1, 2016; and (d) 1,389,438 shares of common stock held by Mr. Green.
F2: The options vest in four equal installments on the first four anniversaries on January 1, 2012.